Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Chenjian Gu and Yutang Li.
Chenjian Gu
Connection Strength
0.409
Yutang Li
  1. Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2. Sci Bull (Beijing). 2021 May 15; 66(9):925-936.
    View in: PubMed
    Score: 0.229
  2. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. Emerg Microbes Infect. 2021 Dec; 10(1):1555-1573.
    View in: PubMed
    Score: 0.061
  3. Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction. Signal Transduct Target Ther. 2021 Jun 10; 6(1):230.
    View in: PubMed
    Score: 0.059
  4. Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction. Signal Transduct Target Ther. 2021 05 18; 6(1):198.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.